Finally, an Expert Network Built for Healthcare Research
Healthcare competitive intelligence is the systematic process of gathering information about competitors, and most mid-market teams can't afford to do it well. You're either paying six-figure annual retainers to GLG or Third Bridge, or you're rolling the dice on marketplace alternatives that cut corners on compliance and expert quality.
The core problem is straightforward. You need reliable primary research on pharma pipelines, medical device competitors, regulatory changes, and KOL sentiment. You need it fast, compliant, and priced for a team that doesn't have a Fortune 500 budget. The global medical device industry is a $500 billion sector. The life sciences market moves on clinical trials, regulatory submissions, and strategic moves that require real-time intelligence. Missing a signal costs more than any expert call ever will.
FieldSignal was built for this. It's an expert network designed for mid-market PE associates, corporate strategy analysts, boutique consultants, and founders who need primary healthcare insights without annual retainers, opaque markups, or compliance risk. You pay per project. You get former pharma executives, medtech insiders, and regulatory specialists. You don't get a sales pitch for a $150,000 subscription.
Why FieldSignal Works for Healthcare Intelligence
Here's what makes it different from every other expert network offering healthcare research:
- Transparent pricing, no opacity. The typical all-in cost per expert call at legacy networks runs $1,300 to $2,000+, with markups buried in credit packs and retainer structures. FieldSignal shows you exactly what the expert receives and what the service costs. No hidden multipliers.
- Pay-per-use for pharma and medtech research projects. No annual retainer. No minimum commitment. You scope a project, you pay for that project. If you need one expert call on a regulatory question, you pay for one call. If you need a panel of clinical researchers, you pay for the panel.
- Healthcare compliance infrastructure equivalent to GLG and AlphaSights. Conflict of interest screening, NDA protocols, legal oversight, expert vetting for regulated domains. Healthcare sector regulations like HIPAA require strict adherence to patient data protection, and best practices for healthcare competitive intelligence emphasize patient data privacy and ethical compliance. FieldSignal treats compliance as non-negotiable.
- No markup on expert honoraria for clinical and regulatory specialists. What the expert charges is what you pay for the expert. The service fee is separate and visible. This matters when you're sourcing former pharma C-suite or KOLs with high hourly rates.
- Access to former pharma executives, medtech insiders, regulatory specialists without a Fortune 500 budget. Subject matter experts across therapeutic areas, medical device manufacturers, clinical trial operations, HTA bodies, and payer organizations. You don't need a hedge fund's spend to reach them.
Instead of forcing you into a year-long contract to access healthcare intelligence, FieldSignal gives you a direct path to the experts and actionable insights your project actually needs.
How It Works
Getting primary healthcare research shouldn't require weeks of procurement and onboarding. The process is three steps.
Step 1: Define Your Healthcare Research Scope
Submit your research brief. This could be a pharma pipeline assessment, a competitive analysis of medtech companies in a specific device category, regulatory intelligence on FDA or EMA approval pathways, or a KOL landscape mapping in a therapeutic area. FieldSignal's scoping process is designed for the timelines healthcare CI demands, whether that's a two-week due diligence sprint or an ongoing monitoring program.
Step 2: Connect With Healthcare Experts
FieldSignal recruits and screens experts matched to your scope. That means former pharma executives, medical device R&D leaders, regulatory affairs specialists, clinical researchers, and KOLs with direct experience in your target market. Compliance screening is equivalent to what GLG, AlphaSights, or Third Bridge provide for healthcare projects: conflict checks, confidentiality agreements, and legal review. Adhering to data privacy is crucial in competitive intelligence practices, and every expert engagement reflects that.
Step 3: Get Actionable Healthcare Insights
Conduct one-on-one interviews, structured surveys, or expert panels. Receive transcripts and analysis focused on what you actually need: competitive positioning, pipeline risk assessment, market entry feasibility, or financial analysis of a target company. Effective competitive intelligence transforms raw data into actionable wisdom. You walk away with strategic insights, not a stack of unprocessed audio files.
No guesswork. No wasted calls. Just structured primary research.
What Makes Us Different
Most expert networks in healthcare serve the same clients: large hedge funds, bulge-bracket banks, Big Four consulting firms. Their pricing reflects that. Here's how FieldSignal compares on the criteria that actually matter for healthcare competitive intelligence.
| Criterion | GLG / Third Bridge / AlphaSights | Guidepoint / Tegus / Capvision | FieldSignal |
|---|---|---|---|
| Pricing model | Annual retainers, typically $30,000 to $200,000+; credit packs with opaque markups | Mix of subscription and pay-per-use; variable transparency | Pay-per-project, no retainer, no minimum spend. Expert honoraria passed through without markup |
| Healthcare expert depth | Broad global networks across therapeutic areas, medtech, payers, regulatory | Good breadth, variable depth in specialized healthcare domains | Targeted recruitment of pharma executives, medtech insiders, regulatory specialists, clinical researchers, KOLs |
| Compliance for regulated projects | Strong multi-layer compliance frameworks, conflict screening, legal oversight | Variable. Some match legacy compliance, others cut corners | Equivalent compliance infrastructure: conflict checks, NDAs, regulatory legal review |
| Speed of expert matching | High for standard requests; premium charges for urgency | Often faster for generalist queries | Built for mid-market speed. Lighter process overhead, faster matching for healthcare-specific scopes |
| Fit for mid-market teams | Overpriced for most PE associates, boutique consultants, founders | Better fit but still often requires larger commitments | Purpose-built. No large lock-ins, better cost control, aligned with smaller project budgets |
The comparison is simple. If you're at a firm that spends six figures annually on expert calls, GLG and Third Bridge serve you well. If you're not, and you still need the same quality of healthcare intelligence with the same compliance rigor, FieldSignal is built for your budget. See our Guidepoint alternatives guide for the broader landscape.
Proof That It Works
Implementing competitive intelligence can improve response to market challenges by 65%. Regular competitor analysis predicts new product success rates. These aren't theoretical claims. They reflect what happens when teams get reliable primary research into their decision making process before committing capital or strategic direction.
Here's what healthcare CI through FieldSignal looks like in practice:
- PE due diligence on a medtech acquisition. A mid-market PE associate needs to assess regulatory risk for a medical device company expanding into the EU. FieldSignal recruits former regulatory affairs executives with direct EU MDR experience. The firm identifies a critical compliance gap before closing, saving months of post-acquisition remediation.
- Pharma pipeline competitive assessment. A corporate strategy team tracks key competitors in neurology across Asia. Expert interviews with former clinical leads and KOLs, combined with clinical trial databases and patent monitoring, reveal a competitor's Phase III readout timeline is six months ahead of public estimates. The team adjusts its own pipeline strategy accordingly. See our pharma competitive intelligence guide for the drug-lifecycle view.
- Market validation for a digital health founder. A founder preparing for a Series A needs to validate demand for a remote patient monitoring platform. FieldSignal connects them with former payer executives and hospital system leaders. The founder identifies the strongest reimbursement pathway and adjusts market positioning before the fundraise.
Regular analysis of competitors predicts new product success. Monitoring competitor strategies helps identify emerging risks and opportunities. These outcomes aren't reserved for teams with Fortune 500 budgets.
Who It's For
FieldSignal is built for teams that need healthcare competitive intelligence without enterprise-scale spending:
- PE/VC associates doing pre-investment research on healthcare companies. You need to understand a target's competitive position, pipeline risk, regulatory exposure, and financial performance before your IC meeting. You don't need a $100,000 annual subscription to get there.
- Corporate strategy teams analyzing pharma and medtech competitive landscapes. Tracking product launches, acquisitions, partnership strategies, and new entrants in your sector. Continuous monitoring of competitor activity gives you early signals to respond to market shifts.
- Boutique consultants conducting primary research for healthcare clients. Your clients expect the same quality of business research they'd get from a McKinsey engagement. You need access to the same caliber of experts without the same overhead.
- Healthcare founders validating market opportunities or competitive positioning. Before you raise, you need a better understanding of your competitive advantage, product differentiation, and the demand from patients and providers. Expert interviews give you that validation.
If you need healthcare intelligence and you've been priced out of legacy networks or burned by low-quality alternatives, this was built for you.
Pricing & Plans
Expert networks in healthcare charge anywhere from $300 to $1,500+ per call, with annual subscriptions ranging from $30,000 to $200,000+. Most of that cost is hidden in credit systems, markups on expert honoraria, and platform fees that aren't disclosed until you're deep into a contract.
FieldSignal's pricing is visible and project-based.
Project-Based Research
Perfect for one-off healthcare CI projects: a due diligence sprint, a competitive analysis, a regulatory assessment. Includes expert recruitment, compliance screening, and interview coordination. You see the per-project cost before you commit. No surprises.
Quarterly Research Programs
Designed for ongoing healthcare competitive monitoring. Includes regular KOL panels, competitive intelligence updates, and regulatory tracking on the topics that matter to your organization. No annual commitment required. Medical device companies should analyze competitors quarterly or biannually, and this program supports that cadence.
Enterprise Healthcare Intelligence
Custom solutions for large-scale healthcare research programs. Dedicated support for pharmaceutical, medical technology, or biotech competitive intelligence. Custom pricing without long-term lock-in.
If you're unsure which model fits, start with a single project. You can scale up anytime.
Frequently Asked Questions
How quickly can I get healthcare experts for my research?
Most healthcare expert matches are completed within days, not weeks. Timelines vary by specialty. Former pharma executives and regulatory specialists in common therapeutic areas are typically available faster than ultra-niche clinical researchers or experts in rare disease. For urgent briefs, FieldSignal prioritizes speed without compromising compliance screening.
Do you have compliance equivalent to GLG for healthcare projects?
Yes. FieldSignal's compliance infrastructure includes conflict of interest screening, NDA execution, expert identity verification, and legal review for regulated healthcare research. This covers pharma, medical device, diagnostics, and biotech projects. Healthcare sector regulations require strict adherence to patient data protection, and every engagement reflects that standard.
What types of healthcare experts can you access?
Former pharma C-suite executives. Medical device R&D leaders. Regulatory affairs specialists (FDA, EMA, HTA bodies). Clinical trial principal investigators. KOLs across therapeutic areas. Payer and reimbursement specialists. Healthcare IT and digital health operators. Hospital and health system executives. The pool covers the healthcare industry broadly and the life sciences sector specifically.
How does your pricing compare to AlphaSights or Third Bridge?
Legacy networks like AlphaSights and Third Bridge typically require annual retainers or enterprise subscriptions, often starting at $30,000 and reaching $200,000+. Per-call costs with markups often land between $1,300 and $2,000+. FieldSignal charges per project with no annual retainer, no minimum spend, and no markup on expert honoraria. You see the expert's rate and the service fee separately. Data from legal public sources enhances competitive intelligence efforts, and you shouldn't have to pay enterprise rates to access the primary research layer on top of it.
Get Started Today
Healthcare competitive intelligence informs strategic planning and decision making. It helps you track competitor activity, anticipate strategic moves, identify new challenges, and gain competitive advantage in the healthcare industry. Continuous monitoring of 200k+ global sources provides early market signals. But the primary research layer, the expert interviews, KOL panels, and regulatory specialist consultations, is where raw data becomes strategic decisions.
You shouldn't need a six-figure annual retainer to access that layer.
FieldSignal gives mid-market teams the same healthcare CI capabilities that Fortune 500 firms get from legacy networks. Transparent pricing, no annual commitment, full compliance, and direct access to the experts who know your market.
Healthcare organizations use public data, commercial databases, and primary research for competitive intelligence. Real-world evidence can provide insights into competitor product performance in clinical settings. Organizations can monitor volume growth and service lines to assess performance in healthcare. All of this intelligence feeds into better strategic decision making.
Get a quote for your research scope. Email miles@fieldsignalhq.com.